Clifford Wlodaver is an Infectious Disease physician affiliated with Rose State College. OpenAlex indexes 18 publications with 242 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8121 National Ave
Ste 310
Midwest City, OK 731107530
Telephone
405-737-3100Registry record last updated 24 Jun 2009.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Paratek Pharmaceuticals, Inc.Program year20251 payment
- SANOFI PASTEUR INC.Program year20241 payment
- Ferring Pharmaceuticals Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
57.2%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor17%Tivicay42%Juluca40%Isentress19%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor13.6%Triumeq73%Descovy27%Part D<11 patients+ 4 more classes in this area
Nervous system
23%gamma-Aminobutyric Acid A Receptor Positive Modulator6.8%Zolpidem Tartrate100%Part D<11 patientsGabapentinoids6%Pregabalin100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
12.5%Thiazide diuretic3.1%Hydrochlorothiazide100%Part D<11 patientsAngiotensin receptor blocker (ARB)3.1%Edarbi100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- PathoBiocheModel of the double-edged sword of glucocorticoids: a case report of COVID-19 management of an outpatient with sarcoidosis
Journal of Medical Artificial Intelligence
2024 - Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications
Frontiers in Medicine
2020 - Antibiotic Stewardship for Non-Infectious Disease Physicians: Focusing on When to Withhold, Modify and Discontinue Antibiotics.
PubMed
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”